The latest research study “Blood Gas and Electrolyte Analyzer Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global blood gas and electrolyte analyzer market reached a value of US$ 1.85 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 2.76 Billion by 2027, exhibiting a CAGR of 6.70% during 2022-2027.
Covid-19 Impact:
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Industry Definition and Application:
Blood gas and electrolyte analyzers represent the medical devices customized for determining several parameters in a whole blood sample, including potential hydrogen (pH), blood gas (partial pressure of carbon dioxide and oxygen), metabolites, and electrolytes. In terms of modality, they are available in benchtop and portable models. Blood gas and electrolyte analyzer products are effective in detecting metabolic imbalances and the measurement of renal and cardiac functions. They aid in measuring the acid-base balance of a patient, diabetes, drug consumption, etc. Blood gas and electrolyte analyzer instruments are cost-effective and provide accurate and fast results. Consequently, they find extensive applications across various establishments, such as hospitals, clinics, ambulatory surgical centers, etc.
Download free sample brochure (Exclusive Offer on this report): https://www.imarcgroup.com/blood-gas-electrolyte-analyzer-market/requestsample
Global Blood Gas and Electrolyte Analyzer Market Trends and Drivers:
The escalating number of patients in operating rooms, intensive care units (ICUs), and emergency departments is primarily driving the blood gas and electrolyte analyzer market. Furthermore, the increasing prevalence of chronic diseases among the geriatric population and the elevating demand for high throughput, integrated, and automated systems are acting as significant growth-inducing factors. Additionally, the growing product usage with laboratory information systems and electronic medical records for streamlining the workflow and enabling effective monitoring of patient health is also positively influencing the market growth. Besides this, the inflating investments by key market players to develop portable product variants with easy-to-use features and minimum maintenance requirements and the shifting preferences toward point-of-care testing (POCT) are expected to propel the blood gas and electrolyte analyzer market over the forecasted period.
| Blood Gas and Electrolyte Analyzer Market Report Scope | |
| Report Coverage | Details |
| Market size value in 2021 | US$ 1.85 Billion |
| Market forecast in 2027 | US$ 2.76 Billion |
| Growth Rate | CAGR of 6.70% from 2022 to 2027 |
| Base year for estimation | 2021 |
| Historical data | 2016-2021 |
| Forecast period | 2022-2027 |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | Product Type, Modality, End User and Region |
| Regional scope | North America, Europe, Asia-Pacific, Latin America, Middle East and Africa |
| Key companies profiled | Abbott Laboratories Inc., Dalko Diagnostics, Erba Group (Transasia Bio-Medicals Ltd.), Medica Corporation, Nova Biomedical Corporation, OPTI Medical Systems Inc. (IDEXX Laboratories), Radiometer Medical ApS (Danaher Corporation), Roche Holding AG, Siemens AG, and WerfenLife S.A. |
| Market Dynamics | Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for forecast period, |
| Customization preview | If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Report Segmentation:
The report has been segmented the market into following categories:
Breakup by Product Type:
- Analyzers
- Consumables
Breakup by Modality:
- Benchtop
- Portable
Breakup by End User:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Others
By Geography:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=5786&flag=C
List of Major Key Players:
The major players in the market are Abbott Laboratories Inc., Dalko Diagnostics, Erba Group (Transasia Bio-Medicals Ltd.), Medica Corporation, Nova Biomedical Corporation, OPTI Medical Systems Inc. (IDEXX Laboratories), Radiometer Medical ApS (Danaher Corporation), Roche Holding AG, Siemens AG, and WerfenLife S.A.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
